# An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

> **NCT00097916** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 34 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** memantine HCl

## Key facts

- **NCT ID:** NCT00097916
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2012-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00097916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00097916, "An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00097916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*